P-45 NF-κB is a potential therapeutictarget in high risk MDS: Induction of apoptosis by bortezomib and BAY 11-7082

Tobias Braun; G Carvalho; Marie‐Catherine Vozenin; Jean‐Jacques Kiladjian; François Hirsch; Pierre Fenaux; Guido Guido Kroemer

doi:10.1016/s0145-2126(05)80109-2

Related publications

Article1997

NF-κB involvement in IL-1β-induction of GM-CSF and COX-2: inhibition by glucocorticoids does not require I-κB

Ian M. Adcock, Robert Newton, Peter J Barnes

Article2007

Disruption of Bcl-2 Heterodimerization by the BH3 Mimetic ABT-737 Restores Spontaneous Apoptosis and Induces Differentiation in High Risk MDS and AML.

Lionel Adès, Simone Boehrer, Thorsten Braun, J. Grosjean, Claire Fabre, Pierre Fenaux, Guido Guido Kroemer

Article2008

ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Jennifer Grosjean-Raillard, Maximilien Tailler, Lionel Adès, Jean‐Luc Perfettini, Claire Fabre, Thomas Braun, Stéphane de Botton, Pierre Fenaux, Guido Guido Kroemer

Article2024

Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy

Nasim Ebrahimi, Al‐Hasnawi Rasool Riyadh Abdulwahid, Atena Mansouri, Nasrin Karimi, Rashid Jafardoust Bostani, Sheida Beiranvand, Samaneh Adelian, Roya Khorram, Reza Vafadar, Michael R Hamblin, Amir Reza Aref

Article2007

NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ

Florian R. Greten, Melek C. Arkan, Julia Bollrath, Li‐Chung Hsu, Jason Goode, Cornelius Miething, Serkan İsmail Göktuna, Michael Neuenhahn, Joshua Fierer, Stephan Paxian, Nico van Rooijen, Yajun Xu, Timothy D. Ocain, Bruce Jaffee, Dirk H. Busch, Justus Duyster, Roland M. Schmid, Lars Eckmann, Michael Karin